Allen Yang
Net worth: 2 M $ as of 30/03/2024
Profile
Allen Yang worked as a Medical Director at Amgen, Inc. and as a Vice President of Clinical Research at Spectrum Pharmaceuticals, Inc. He then became the Chief Medical Officer and Senior Vice President at Xencor, Inc. from 2019 to 2023.
He also worked as the VP and Therapeutic Area Head of Hematology/Oncology at Jazz Pharmaceuticals Plc.
Dr. Yang holds a doctorate from the University of Southern California and an undergraduate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XENCOR, INC.
0.12% | 08/03/2023 | 73,364 ( 0.12% ) | 2 M $ | 30/03/2024 |
Former positions of Allen Yang
| Companies | Position | End |
|---|---|---|
| XENCOR, INC. | Chief Tech/Sci/R&D Officer | 30/04/2023 |
| AMGEN INC. | Corporate Officer/Principal | - |
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 31/12/2018 |
Training of Allen Yang
| University of Southern California | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
- Stock Market
- Insiders
- Allen Yang
